128 related articles for article (PubMed ID: 33602100)
1. Relationship with Programmed Cell Death Ligand 1 (PD-L1) and DTI Features in Brain Metastases of Non-small Cell Lung Cancer: A Preliminary Study.
Yilmaz TF; Yurtsever I; Turk HM; Gultekin MA; Besiroglu M; Cesme DH; Shbair ATM; Alkan A
Curr Med Imaging; 2021; 17(11):1369-1373. PubMed ID: 33602100
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of PD-1/L1 inhibitors in brain metastases of non-small-cell lung cancer: pooled analysis from seven randomized controlled trials.
Li W; Jiang J; Huang L; Long F
Future Oncol; 2022 Jan; 18(3):403-412. PubMed ID: 34787500
[TBL] [Abstract][Full Text] [Related]
3. Programmed Death Receptor Ligand One Expression May Independently Predict Survival in Patients With Non-Small Cell Lung Carcinoma Brain Metastases Receiving Immunotherapy.
Hulsbergen AFC; Mammi M; Nagtegaal SHJ; Lak AM; Kavouridis V; Smith TR; Iorgulescu JB; Mekary RA; Verhoeff JJC; Broekman MLD; Phillips JG
Int J Radiat Oncol Biol Phys; 2020 Sep; 108(1):258-267. PubMed ID: 32335185
[TBL] [Abstract][Full Text] [Related]
4. Clinical Significance of PD-L1 Expression in Brain Metastases from Non-small Cell Lung Cancer.
Takamori S; Toyokawa G; Okamoto I; Takada K; Kinoshita F; Kozuma Y; Matsubara T; Haratake N; Akamine T; Mukae N; Hirai F; Tagawa T; Oda Y; Iwaki T; Iihara K; Nakanishi Y; Maehara Y
Anticancer Res; 2018 Jan; 38(1):553-557. PubMed ID: 29277823
[TBL] [Abstract][Full Text] [Related]
5. The Utility and Efficiency of Diffusion Tensor Imaging Values to Determine Epidermal Growth Factor Receptor Gene Mutation Status in Brain Metastasis from Lung Adenocarcinoma; A Preliminary Study.
Gultekin MA; Turk HM; Yurtsever I; Atasoy B; Aliyev A; Yilmaz TF; Alkan A
Curr Med Imaging; 2020; 16(10):1271-1277. PubMed ID: 33461445
[TBL] [Abstract][Full Text] [Related]
6. PD-L1 expression and tumor mutational burden status for prediction of response to chemotherapy and targeted therapy in non-small cell lung cancer.
Chen Y; Liu Q; Chen Z; Wang Y; Yang W; Hu Y; Han W; Zeng H; Ma H; Dai J; Zhang H
J Exp Clin Cancer Res; 2019 May; 38(1):193. PubMed ID: 31088500
[TBL] [Abstract][Full Text] [Related]
7. Radiomics for the non-invasive prediction of PD-L1 expression in patients with brain metastases secondary to non-small cell lung cancer.
Meißner AK; Gutsche R; Galldiks N; Kocher M; Jünger ST; Eich ML; Nogova L; Araceli T; Schmidt NO; Ruge MI; Goldbrunner R; Proescholdt M; Grau S; Lohmann P
J Neurooncol; 2023 Jul; 163(3):597-605. PubMed ID: 37382806
[TBL] [Abstract][Full Text] [Related]
8. Diffusion Tensor Imaging Can Discriminate the Primary Cell Type of Intracranial Metastases for Patients with Lung Cancer.
Bilgin SS; Gultekin MA; Yurtsever I; Yilmaz TF; Cesme DH; Bilgin M; Topcu A; Besiroglu M; Turk HM; Alkan A; Bilgin M
Magn Reson Med Sci; 2022 Jul; 21(3):425-431. PubMed ID: 33658441
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes and predictive value of programmed cell death-ligand 1 expression in response to anti-programmed cell death 1/ligand 1 antibodies in non-small cell lung cancer patients with performance status 2 or greater.
Jodai T; Saruwatari K; Ikeda T; Moriyama E; Kashiwabara K; Shingu N; Iyonaga K; Inaba M; Ajishi Y; Honda C; Hirosako S; Maruyama H; Kakiuchi Y; Eida H; Tomita Y; Saeki S; Ichiyasu H; Sakagami T
Int J Clin Oncol; 2021 Jan; 26(1):78-86. PubMed ID: 32965577
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of PD
Lu J; Feng J; Zheng H; Wen Q; Fan S
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 45(10):1149-1154. PubMed ID: 33268574
[TBL] [Abstract][Full Text] [Related]
11. [Real-world study on the efficacy and prognostic predictive biomarker of patients with metastatic non-small cell lung cancer treated with programmed death-1/programmed death ligand 1 inhibitors].
Zhu WJ; Zhu HH; Liu YT; Lin L; Xing PY; Hao XZ; Cong MH; Wang HY; Wang Y; Li JL; Feng Y; Hu XS
Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):416-424. PubMed ID: 35615798
[No Abstract] [Full Text] [Related]
12. Association between
Zhao L; Liu J; Wang H; Shi J
Br J Radiol; 2021 Mar; 94(1119):20200397. PubMed ID: 33492995
[TBL] [Abstract][Full Text] [Related]
13. Association of PD-L1 expression and PD-L1 gene polymorphism with poor prognosis in lung adenocarcinoma and squamous cell carcinoma.
Yeo MK; Choi SY; Seong IO; Suh KS; Kim JM; Kim KH
Hum Pathol; 2017 Oct; 68():103-111. PubMed ID: 28851662
[TBL] [Abstract][Full Text] [Related]
14. B7-1 and programmed cell death-ligand 1 in primary and lymph node metastasis lesions of non-small cell lung carcinoma.
Yamada T; Miki Y; Suzuki M; Kondoh O; Saito-Koyama R; Ono K; Okada Y; Sasano H
Cancer Med; 2022 Jan; 11(2):479-491. PubMed ID: 34907653
[TBL] [Abstract][Full Text] [Related]
15. Poor efficacy of anti-programmed cell death-1/ligand 1 monotherapy for non-small cell lung cancer patients with active brain metastases.
Tozuka T; Kitazono S; Sakamoto H; Yoshida H; Amino Y; Uematsu S; Yoshizawa T; Hasegawa T; Ariyasu R; Uchibori K; Yanagitani N; Horai T; Seike M; Gemma A; Nishio M
Thorac Cancer; 2020 Sep; 11(9):2465-2472. PubMed ID: 32657011
[TBL] [Abstract][Full Text] [Related]
16. Concordance of PD-L1 expression and CD8+ TIL intensity between NSCLC and synchronous brain metastases.
Batur S; Dulger O; Durak S; Yumuk PF; Caglar HB; Bozkurtlar E; Bozkurt S; Tastekin E; Cicin I; Ahiskali R; Rzazade R; Cakir A; Oz B
Bosn J Basic Med Sci; 2020 Aug; 20(3):329-335. PubMed ID: 31999935
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of pembrolizumab in patients with brain metastasis caused by previously untreated non-small cell lung cancer with high tumor PD-L1 expression.
Wakuda K; Yabe M; Kodama H; Nishioka N; Miyawaki T; Miyawaki E; Mamesaya N; Kawamura T; Kobayashi H; Omori S; Ono A; Kenmotsu H; Naito T; Murakami H; Harada H; Endo M; Gon Y; Takahashi T
Lung Cancer; 2021 Jan; 151():60-68. PubMed ID: 33246646
[TBL] [Abstract][Full Text] [Related]
18. Expression of phosphatase and tensin homolog and programmed cell death ligand 1 in adenosquamous carcinoma of the lung.
Hlaing AM; Furusato B; Udo E; Kitamura Y; Souda M; Masutani M; Fukuoka J
Biochem Biophys Res Commun; 2018 Sep; 503(4):2764-2769. PubMed ID: 30100056
[TBL] [Abstract][Full Text] [Related]
19. A Comprehensive Analysis of Programmed Cell Death Ligand-1 Expression With the Clone SP142 Antibody in Non-Small-Cell Lung Cancer Patients.
Takada K; Toyokawa G; Okamoto T; Shimokawa M; Kozuma Y; Matsubara T; Haratake N; Akamine T; Takamori S; Katsura M; Shoji F; Oda Y; Maehara Y
Clin Lung Cancer; 2017 Sep; 18(5):572-582.e1. PubMed ID: 28318951
[TBL] [Abstract][Full Text] [Related]
20. Quantitative analysis in peritumoral volumes of brain metastases treated with stereotactic radiotherapy.
Kim MS; Park SH; Park ES; Park JB; Kwon SC; Lyo IU; Sim HB
J Neuroradiol; 2018 Sep; 45(5):310-315. PubMed ID: 29410152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
